Monoclonal antibodies show promise as new therapy for veterinary patients
AVMA News
NOVEMBER 21, 2023
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat cancer and autoimmune disorders. The power of mAbs is now being unleashed for debilitating diseases in dogs and cats, including atopic dermatitis, pain associated with osteoarthritis, and canine parvovirus.
Let's personalize your content